Bioavailability Study of 6 Mercaptopurine in Crohns Disease Patients

Study Title
Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients
Teva Identifier
C1/13/6MP-02
ClinicalTrials.gov Identifier
NCT00774982
Study Status
Completed
Trial Condition(s)
Crohns Disease
Interventions
Drug: Delayed Release 6 mercaptopurine | Drug: 6 Mercaptopurine

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 50 Years
Trial Duration
12/01/2008 - 02/01/2009
Phase
Phase 1

Study Type

Interventional